| |
ANDA Number |
Generic Drug Name |
Applicant |
Approval Date |
| 1 |
77-880 |
METFORMIN HYDROCHLORIDE TABLETS USP, 500 MG, 850 MG, AND 1000 MG |
INTERPHARM, INC. |
6/5/2006 |
| 2 |
77-018 |
METRONIDAZOLE TOPICAL GEL, 0.75% |
ALTANA INC. |
6/6/2006 |
| 3 |
77-440 |
POTASSIUM CITRATE EXTENDED-RELEASE TABLETS USP, 5 mEq AND 10 mEq |
COREPHARMA, LLC |
6/8/2006 |
| 4 |
40-671 |
TRIAMCINOLONE ACETONIDE CREAM USP, 0.025% AND 0.1% |
VINTAGE PHARMACEUTICALS, LLC |
6/9/2006 |
| 5 |
40-575 |
TESTOSTERONE ENANTHATE INJECTION USP, 200 MG/ML; 5 ML MULTIPLE-DOSE VIALS |
PADDOCK LABORATORIES, INC. |
6/14/2006 |
| 6 |
77-629 |
CITALOPRAM HYDROBROMIDE ORAL SOLUTION, 10 MG (BASE)/5 ML |
SILARX PHARMACEUTICALS, INC. |
6/14/2006 |
| 7 |
65-322 |
AMOXICILLIN FOR ORAL SUSPENSION USP, 125 MG/5 ML AND 250 MG/5 ML |
HIKMA PHARMACEUTICALS |
6/19/2006 |
| 8 |
65-325 |
AMOXICILLIN FOR ORAL SUSPENSION USP, 200 MG/5 ML AND 400 MG/5 ML |
HIKMA PHARMACEUTICALS |
6/19/2006 |
| 9 |
76-340 |
FINASTERIDE TABLETS USP, 5 MG |
IVAX PHARMACEUTICALS, INC. |
6/19/2006 |
| 10 |
77-401 |
MOMETASONE FUROATE OINTMENT USP, 0.1% |
G & W LABORATORIES, INC. |
6/20/2006 |
| 11 |
77-690 |
QUINAPRIL TABLETS USP, 5 MG, 10 MG, 20 MG, AND 40 MG |
LUPIN LIMITED |
6/20/2006 |
| 12 |
77-965 |
NORTRIPTYLINE HYDROCHLORIDE ORAL SOLUTION USP, 10 MG (BASE)/5 ML |
TARO PHARMACEUTICAL INDUSTRIES, LTD. |
6/20/2006 |
| 13 |
76-420 |
LAMOTRIGINE TABLETS, (CHEWABLE) 5 MG AND 25 MG |
TEVA PHARMACEUTICALS USA |
6/21/2006 |
| 14 |
76-052 |
SIMVASTATIN TABLETS USP, 5 MG, 10 MG, 20 MG, AND 40 MG |
IVAX PHARMACEUTICALS, INC. |
6/23/2006 |
| 15 |
76-285 |
SIMVASTATIN TABLETS USP, 80 MG |
RANBAXY INC. |
6/23/2006 |
| 16 |
77-613 |
ANAGRELIDE HYDROCHLORIDE CAPSULES, 0.5 MG (BASE) AND 1 MG (BASE) |
ALPHAPHARM PTY, LTD. |
6/27/2006 |
| 17 |
40-668 |
CYPROHEPTADINE HYDROCHLORIDE SYRUP USP, 2 MG/5 ML |
LYNE LABORATORIES |
6/28/2006 |
| 18 |
77-856 |
CLONAZEPAM TABLETS USP, 0.5 MG, 1 MG, AND 2 MG |
VINTAGE PHARMACEUTICALS, LLC |
6/28/2006 |
| 19 |
40-640 |
TRANYLCYPROMINE SULFATE TABLETS, 10 MG (BASE) |
KALI LABORATORIES, INC. |
6/29/2006 |
| 20 |
65-262 |
CEFTRIAXONE FOR INJECTION USP, 1 G/100 ML AND 2 G/100 ML |
TEVA PHARMACEUTICALS USA |
6/29/2006 |
| 21 |
77-421 |
LORATADINE ORAL SOLUTION USP, (OTC) 5 MG/5 ML |
SILARX PHARMACEUTICALS, INC. |
6/29/2006 |
| 22 |
65-202 |
CEFPROZIL FOR ORAL SUSPENSION USP, 125 MG/5 ML AND 250 MG/5 ML |
RANBAXY LABORATORIES LIMITED |
6/30/2006 |
| 23 |
75-719 |
SERTRALINE HYDROCHLORIDE TABLETS, 25 MG (BASE), 50 MG (BASE), AND 100 MG (BASE) |
IVAX PHARMACEUTICALS, INC. |
6/30/2006 |
| 24 |
76-934 |
SERTRALINE HYDROCHLORIDE ORAL CONCENTRATE, 20 MG (BASE)/ML |
ROXANE LABORATORIES, INC. |
6/30/2006 |
| 25 |
77-055 |
FLUTICASONE PROPIONATE CREAM, 0.05% |
G & W LABORATORIES, INC. |
6/30/2006 |
| 26 |
77-777 |
ALPRAZOLAM EXTENDED-RELEASE TABLETS, 0.5 MG, 1 MG, 2 MG, AND 3 MG |
SANDOZ INC. |
6/30/2006 |
